- Home
- AMRX
as of 12-09-2025 3:58pm EST
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 3.8B | IPO Year: | N/A |
| Target Price: | $13.25 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.68 - $12.68 | Next Earning Date: | 10-30-2025 |
| Revenue: | $2,934,959,000 | Revenue Growth: | 9.50% |
| Revenue Growth (this year): | 9.99% | Revenue Growth (next year): | 6.67% |
AI-Powered AMRX Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Amneal Pharmaceuticals Inc. (AMRX)
Director
Avg Cost/Share
$11.72
Shares
50,000
Total Value
$586,000.00
Owned After
291,029
SEC Form 4
Executive Vice President
Avg Cost/Share
$11.92
Shares
131,856
Total Value
$1,571,723.52
Owned After
146,403
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Nark Ted C | AMRX | Director | Nov 17, 2025 | Sell | $11.72 | 50,000 | $586,000.00 | 291,029 | |
| Shah Nikita | AMRX | Executive Vice President | Nov 12, 2025 | Sell | $11.92 | 131,856 | $1,571,723.52 | 146,403 |
Compare AMRX vs Leading Stocks
See how AMRX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AMRX Amneal Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.